🔗 Share this article

Chancellor Rachel Reeves has stated she is preparing "targeted steps to tackle cost of living issues" in the forthcoming Budget.

During an interview with media outlets, she emphasized that reducing price rises is a collective task of both the government and the central bank.

The United Kingdom's price growth is forecast to be the most elevated among the Group of Seven developed nations this year and the following year.

Possible Energy Cost Interventions

Reports indicate the administration could intervene to lower energy bills, for instance by slashing the present 5% level of VAT charged on energy supplies.

A further option is to cut some of the policy costs currently added to bills.

Budgetary Limitations and Analyst Predictions

The administration will receive the next report from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will reveal how much space there is for these actions.

The view from most economists is that the Chancellor will have to introduce higher taxes or expenditure reductions in order to meet her declared borrowing rules.

Earlier on Thursday, calculations suggested there was a £22bn shortfall for the Treasury chief to resolve, which is at the lower end of expectations.

"There's a joint responsibility between the central bank and the administration to bear down further on some of the sources of inflation," the Chancellor stated to reporters in the US capital, at the conferences of the International Monetary Fund and global financial institution.

Revenue Pledges and International Concerns

While a great deal of the focus has been on probable tax increases, the chancellor said the most recent figures from the fiscal watchdog had not altered her vow to manifesto promises not to increase tax levels on income tax, VAT or National Insurance.

She attributed an "uncertain global environment" with growing geopolitical and commercial issues for the Budget revenue measures, likely to be focused on those "wealthiest."

International Trade Disputes

Referring to apprehensions about the United Kingdom's commercial links with the Asian nation she said: "The UK's national security always take priority."

Last week's announcement by Chinese authorities to tighten export controls on critical minerals and other resources that are key for advanced tech manufacturing led US President Donald Trump to threaten an additional 100% import tax on imports from the Asian country, raising the prospect of an full-scale commercial conflict between the two economic giants.

The American finance chief labeled the Chinese action "economic coercion" and "a international production power grab."

Asked about considering the US offer to join its battle with the Asian nation, the Chancellor said she was "extremely troubled" by China's measures and called on the Chinese government "to avoid restrictions and limit trade."

She said the move was "harmful for the international commerce and causes further challenges."

"In my view there are sectors where we must confront Chinese policies, but there are also important opportunities to sell into Chinese markets, including financial services and other areas of the economic system. We've got to achieve that balance appropriate."

The Treasury chief also affirmed she was working with other major economies "on our own critical minerals plan, so that we are reduced dependence."

Health Service Medicine Pricing and Funding

The Chancellor also acknowledged that the cost the National Health Service pays for pharmaceuticals could go up as a result of current talks with the US government and its drugs companies, in exchange for reduced taxes and investment.

A number of the world's largest drug companies have said in recent statements that they are either halting or canceling operations in the United Kingdom, with several blaming the modest returns they are receiving.

Last month, the government science advisor said the cost the NHS spends on drugs would must go up to prevent firms and drug research funding departing from the United Kingdom.

The Chancellor informed the BBC: "It has been observed because of the payment system, that medical research, recent pharmaceuticals have not been provided in the United Kingdom in the extent that they are in other European countries."

"Our aim is to ensure that patients getting care from the NHS are able to obtain the top life-saving treatments in the globe. And so we are reviewing this situation, and... looking to secure additional investment into the UK."